^
Association details:
| Biomarker: | EGFR expression |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug: | Gilotrif (afatinib) (EGFR inhibitor, HER2 inhibitor, HER4 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
P6 - The Drowned Lung: An Unusual Case of Lepidic Adenocarcinoma
Published date:
07/04/2020
Excerpt:
A 62-year-old man with 40 pack year smoking history was diagnosed with a 2.9 cm Stage IV EGFR positive adenocarcinoma of the RUL with hypermetabolic activity on positron emission tomography-computed tomography (PET-CT). The patient underwent target immunotherapy with afatinib. Re-staging scans demonstrated decrease in size of the known RUL malignancy but increasing area of consolidation in the RLL suggesting a narrowed bronchus intermedius.
